United States (US) Pharmacogenetic Testing Market (2025-2031) | Growth, Size & Revenue, Forecast, Trends, Companies, Outlook, Value, Share, Competitive Landscape, Segmentation, Industry, Analysis
Market Forecast By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests), By Gene Type (CYP2C19, CYP2D6, CYP2C9 and VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, Others), By Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-the-Counter Medications), By Sample (Blood, Saliva), By Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Others), By Application (Clinical Practice, Drug Development, Drug Regulation), By End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Centres and Academic Institutes, Others) And Competitive Landscape
| Product Code: ETC9973419 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) Pharmacogenetic Testing Market Outlook
- Market Size of United States (US) Pharmacogenetic Testing Market, 2024
- Forecast of United States (US) Pharmacogenetic Testing Market, 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Revenues & Volume for the Period 2021- 2031
- United States (US) Pharmacogenetic Testing Market Trend Evolution
- United States (US) Pharmacogenetic Testing Market Drivers and Challenges
- United States (US) Pharmacogenetic Testing Price Trends
- United States (US) Pharmacogenetic Testing Porter's Five Forces
- United States (US) Pharmacogenetic Testing Industry Life Cycle
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Whole Genome Sequencing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Whole Exome Sequencing for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Array-Based Tests for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Single Gene Tests for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Gene Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By CYP2C19 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By CYP2D6 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By CYP2C9 and VKORC1 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By CYP1A2 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By HLA-B*1502 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By HLA-B*5701 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Drug Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Prescription Drugs for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Nutraceuticals for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Recreational Drugs for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Herbal Supplements for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Vitamins for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Over-the-Counter Medications for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Sample for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Blood for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Saliva for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Therapeutic Area for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Cardiology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Gastroenterology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Anesthesiology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Genomics for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Endocrinology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Immunology & Hypersensitivity for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Dermatology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Application for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Clinical Practice for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Drug Development for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Drug Regulation for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By End User for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Healthcare Providers for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Pharmaceutical & Biotechnology Companies for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Centres and Academic Institutes for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Pharmacogenetic Testing Market Revenues & Volume By Others for the Period 2021- 2031
- United States (US) Pharmacogenetic Testing Import Export Trade Statistics
- Market Opportunity Assessment By Type
- Market Opportunity Assessment By Gene Type
- Market Opportunity Assessment By Drug Type
- Market Opportunity Assessment By Sample
- Market Opportunity Assessment By Therapeutic Area
- Market Opportunity Assessment By Application
- Market Opportunity Assessment By End User
- United States (US) Pharmacogenetic Testing Top Companies Market Share
- United States (US) Pharmacogenetic Testing Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Pharmacogenetic Testing Company Profiles
- United States (US) Pharmacogenetic Testing Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) Pharmacogenetic Testing Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Pharmacogenetic Testing Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Pharmacogenetic Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 United States (US) Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 United States (US) Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Rising prevalence of chronic diseases requiring personalized treatment approaches |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing and reimbursement challenges |
4.3.2 Limited insurance coverage for pharmacogenetic testing leading to affordability issues |
4.3.3 Lack of standardized guidelines and regulations for pharmacogenetic testing |
5 United States (US) Pharmacogenetic Testing Market Trends |
6 United States (US) Pharmacogenetic Testing Market, By Types |
6.1 United States (US) Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 United States (US) Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 United States (US) Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 United States (US) Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 United States (US) Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 United States (US) Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United States (US) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 United States (US) Pharmacogenetic Testing Market Export to Major Countries |
7.2 United States (US) Pharmacogenetic Testing Market Imports from Major Countries |
8 United States (US) Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of clinical studies and research publications supporting the efficacy of pharmacogenetic testing |
8.3 Rate of incorporation of pharmacogenetic testing into clinical practice and treatment decision-making |
8.4 Patient satisfaction and outcomes improvement after undergoing pharmacogenetic testing |
8.5 Number of partnerships and collaborations between pharmaceutical companies, diagnostic laboratories, and healthcare providers for promoting pharmacogenetic testing |
9 United States (US) Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 United States (US) Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Pharmacogenetic Testing Market - Competitive Landscape |
10.1 United States (US) Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential assessment - trade Analytics for 2030
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Thought Leadership and Analyst Meet
Our Clients
Latest Reports
- United Kingdom (UK) Long-term Care Insurance Market (2026-2032) | Growth, Share, Consumer Insights, Drivers, Opportunities, Competition, Pricing Analysis, Segments, Restraints, Companies, Competitive, Value, Outlook, Size, Demand, Analysis, Challenges, Strategic Insights, Investment Trends, Revenue, Trends, Supply, Forecast
- United Kingdom (UK) Long Term Care Market (2026-2032) | Companies, Outlook, Analysis, Trends, Value, Revenue, Segmentation, Share, Forecast, Competitive Landscape, Growth, Size & Forecast
- Iraq Insulation and Waterproofing Market (2026-2032) | Outlook, Drivers, Growth, Size, Share, Industry, Revenue, Trends, Demand, Competitive, Strategic Insights, Opportunities, Segments, Companies, Challenges, Strategy, Consumer Insights, Analysis, Investment Trends, Value, Segmentation, Forecast, Restraints
- India Switchgear Market Outlook (2026 - 2032) | Size, Share, Trends, Growth, Revenue, Forecast, Analysis, Value, Outlook
- Pakistan Contraceptive Implants Market (2025-2031) | Demand, Growth, Size, Share, Industry, Pricing Analysis, Competitive, Strategic Insights, Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Companies, Challenges
- Sri Lanka Packaging Market (2026-2032) | Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges, Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints
- India Kids Watches Market (2026-2032) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Saudi Arabia Core Assurance Service Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Romania Uninterruptible Power Supply (UPS) Market (2026-2032) | Industry, Analysis, Revenue, Size, Forecast, Outlook, Value, Trends, Share, Growth & Companies
- Saudi Arabia Car Window Tinting Film, Paint Protection Film (PPF), and Ceramic Coating Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
Industry Events and Analyst Meet
India EV Show 2026
EV tech India Expo 2026
Auto Tech Asia 2026
Battery Tech India 2026
Smart Production Solutions Guangzhou 2026
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
